Document 0433
 DOCN  M9550433
 TI    [Colony stimulating factors in blood formation]
 DT    9505
 AU    Goebel M; Hoffmann-La Roche Ltd., Basel, Schweiz.
 SO    Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:51-6. Unique
       Identifier : AIDSLINE MED/95143929
 AB    The aim of this article is to review the present state of knowledge of
       the clinical effects of the colony-stimulating factors. Clinical
       experience and publications on this subject are used for this purpose.
       Colony-stimulating factors are being successfully used in various
       diseases and clinical situations, particularly in the area of
       hematology/oncology. However, numerous questions still remain. There are
       many new untested areas in which filgrastim could be employed. New
       indications and open questions require suitable new studies.
 DE    Acquired Immunodeficiency Syndrome/IMMUNOLOGY/THERAPY  Combined Modality
       Therapy  English Abstract  Granulocyte Colony-Stimulating
       Factor/*ADMINISTRATION & DOSAGE/  ADVERSE EFFECTS
       Granulocyte-Macrophage Colony-Stimulating Factor/*ADMINISTRATION  &
       DOSAGE/ADVERSE EFFECTS  Human  Neutropenia/ETIOLOGY/IMMUNOLOGY/*THERAPY
       Palliative Treatment  Recombinant Proteins/ADMINISTRATION &
       DOSAGE/ADVERSE EFFECTS  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).